Chances and challenges of diagnosing primary vitreoretinal lymphoma

doi:10.3877/cma.j.issn.2095-2007.2022.02.001

Abstract

Abstract:

The patients with primary vitreoretinal lymphoma (PVRL) had a short survival and high mortality, thus urge early diagnosis of this disease was helpful to have the survival superiority. However, due to the variety of clinical manifestations of PVRL, the lack of specificity of imaging examination and the low diagnostic rate of pathology as the gold standard, clinicians were inspirited to find more easy-to-use and valuable methods to assist diagnosis. The detection methods such as cytokines, immunohistochemistry, molecular biology and molecular genetics were of benefit to improve the diagnosis rate, but it was important for ophthalmologists to improve the comprehension of the manifestations and imaging characteristics of PVRL and actively explore more reliable and scientific methods based on the available detection methods.

Key words: Primary vitreoretinal lymphoma, Clinical manifestations, Diagnosis

Wei Jia, Haiyan Wang, Ru Wang, Yong Tao, Xuan Huang. Chances and challenges of diagnosing primary vitreoretinal lymphoma[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(02): 65-69.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2022.02.001

https://zhykyxzz.cma-cmc.com.cn/EN/Y2022/V12/I02/65

Figures/Tables 1

References 52

[13]	Brown SM, Jampol LM, Cantrill HL. Intraocular lymphoma presenting as retinal vasculitis[J]. Surv Ophthalmol, 1994, 39(2)：133-140.
[14]	Katoch D, Bansal R, Nijhawan R, et al. Primary intraocular central nervous system lymphoma masquerading as diffuse retinal vasculitis[J]. BMJ Case Rep, 2013: 9354.
[15]	Hedayatfar A, Phaik Chee S. Presumptive primary intraocular lymphoma presented as an intraocular mass involving the optic nerve head[J]. J Ophthalmic Inflamm Infect, 2012, 2(1): 49-51.
[16]	Araujo I, Coupland SE. Primary Vitreoretinal Lymphoma-A Review[J]. Asia Pac J Ophthalmol (Phila), 2017, 6(3): 283-289.
[17]	Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma[J]. Retina, 2002, 22(1): 37-43.
[18]	Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma[J]. Am J Ophthalmol, 2009, 147(5): 886-894.
[19]	Casady M, Faia L, Nazemzadeh M, et al. Fundus autofluorescence patterns in primary intraocular lymphoma[J]. Retina, 2014, 34(2): 366-372.
[20]	Egawa M, Mitamura Y, Hayashi Y, et al. Spectral-domain optical coherence tomographic and fundus autofluorescence findings in eyes with primary intraocular lymphoma[J]. Clin Ophthalmol, 2014, 8: 335-341.
[21]	赵慧英，管文雪，马雅，等. 原发性玻璃体视网膜淋巴瘤患眼光相干断层扫描图像特征[J]. 中华眼底病杂志，2021，37(2)：133-137.
[22]	Saito T, Ohguro N, Iwahashi C, et al. Optical coherence tomography manifestations of primary vitreoretinal lymphoma[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(12): 2319-2326.
[23]	Deák GG, Goldstein DA, Zhou M, et al. Vertical Hyperreflective Lesions on Optical Coherence Tomography in Vitreoretinal Lymphoma[J]. JAMA Ophthalmol, 2019, 137(2): 194-198.
[24]	Barry RJ, Tasiopoulou A, Murray PI, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis[J]. Br J Ophthalmol, 2018, 102(10): 1362-1366.
[25]	DeAngelis LM. Primary central nervous system lymphoma[J]. Curr Opin Neurol, 1999, 12(6): 687-691.
[26]	Coupland SE, Perez-Canto A, Hummel M, et al. Assessment of HOPE fixation in vitrectomy specim ens in patients with chronic bilateral uveitis (masquerade syndrome)[J]. Graefes Arch Clin Exp Ophthalmol, 2005, 243(9): 847-852.
[27]	Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management[J]. Cancer Control, 2004, 11(5): 285-295.
[28]	Kimura K, Usui Y, Goto H. Japanese Intraocular Lymphoma Study Group. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma[J]. Jpn J Ophthalmol, 2012, 56(4): 383-389.
[29]	Lai J, Chen K, Shi HM, et al. B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement[J]. Int J Ophthalmol, 2019, 12(6): 1001-1007.
[30]	Pochat-Cotilloux C, Bienvenu J, Nguyen AM, et al. Use of a threshold of interleukin-10 and il-10/il-6 ratio in ocular samples for the screening of vitreoretinal lymphoma[J]. Retina, 2018, 38(4): 773-781.
[31]	Lee J, Kim SW, Kim H, et al. Differential diagnosis for vitreoretinal lymphoma with vitreoretinal findings, immunoglobulin clonality tests and interleukin levels[J]. Retina, 2019, 39(6): 1165-1176.
[32]	De Hoog J, Dik WA, Lu L, et al. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma[J]. Acta Ophthalmol, 2019, 97(6): 626-632.
[33]	Kuo DE, Wei MM, Knickelbein JE, et al. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels[J]. Ophthalmology, 2020, 127(7): 956-962.
[34]	Kawamura H, Yasuda N, Kakinoki M, et al. Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate[J]. Ophthalmic Res, 2009, 42(3): 172-174.
[35]	Kuiper J, Ten Dam-van Loon N, Domanian A, et al. Correlation between measurement of IL-10 and IL-6 in paired aqueous humour and vitreous fluid in primary vitreoretinal lymphoma[J]. Acta Ophthalmol, 2015, 93(8): e680-681.
[36]	Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma[J]. Invest Ophthalmol Vis Sci, 2007, 48(7): 3253-3259.
[37]	Wolf LA, Reed GF, Buggage RR, et al. Vitreous cytokine levels[J]. Ophthalmology, 2003, 110(8): 1671-1672.
[38]	Wang Y, Shen D, Wang VM, et al. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma[J]. Int J Mol Sci, 2011, 12(9): 5684-5697.
[39]	Costopoulos M, Touitou V, Golmard JL, et al. ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis[J]. Ophthalmology, 2016, 123(7): 1626-1628.
[40]	Chen K, Li X, Wang D, et al. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma[J]. Clin Chim Acta, 2021, 515: 21-26.
[41]	Missotten T, Tielemans D, Bromberg JE, et al. Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma[J]. Ophthalmology, 2013, 120(5): 991-996.
[42]	Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry[J]. Am J Ophthalmol, 1997, 124(3): 362-372.
[43]	Chan CC. Molecular pathology of primary intraocular lymphoma[J]．Trans Am Ophthalmol Soc, 2003, 101: 275-292.
[44]	Merle-Béral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma[J]. Br J Haematol, 2004, 124: 469-473.
[1]	Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an InternationalPrimary Central Nervous System Lymphoma Collaborative Group Report[J]. Ann Oncol, 2007, 18(11): 1851-1855.
[2]	Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report[J]. Neurology, 2008, 71(17): 1355-1360.
[3]	Hormigo A, Abrey L, Heinemann MH, et al. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment[J]. Br J Haematol, 2004, 126(2): 202-208.
[4]	Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma: Clinical and histopathologic diagnosis[J]. Ophthalmology, 1993, 100(9): 1399-1406.
[5]	Kalogeropoulos D, Vartholomatos G, Mitra A, et al. Primary vitreoretinal lymphoma[J]. Saudi J Ophthalmol, 2019, 33(1): 66-80.
[6]	Zhao XY, Cheng TT, Meng LH, et al. Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma[J]. Front. Oncol, 2022, 12: 808511.
[7]	Meunier J, Lumbroso-Le Rouic L, Vincent-Salomon A, et al. Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors[J]. Hematol Oncol, 2004, 22(4): 143-158.
[8]	Coupland SE, Damato B. Understanding intraocular lymphomas[J]. Clin Exp Ophthalmol, 2008, 36(6): 564-578.
[9]	Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma[J]. Discov Med, 2013, 15(81): 93-100.
[10]	AlQahtani A, Touitou V, Cassoux N, et al. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas[J]. Ocul Immunol Inflamm, 2014, 22(3): 189-196.
[11]	Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium[J]. Oncologist, 2011, 16(11): 1589-1599.
[12]	Faia LJ, Chan CC. Primary intraocular lymphoma[J]. Arch Pathol Lab Med, 2009, 133(8): 1228-1232.
[45]	Lobo A, Okhravi N, Adamson P, et al. Protocol for the use of polymerase chain reaction in the detection of intraocular large B-cell lymphoma in ocular samples[J]. J Mol Diagn, 2007, 9: 113-121.
[46]	Narasimhan S, Joshi M, Parameswaran S, et al. MYD88 L265P mutation in intraocular lymphoma: A potential diagnostic marker[J]. Indian J Ophthalmol, 2020, 68(10): 2160-2165.
[47]	Bonzheim I, Giese S, Deuter C, et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates[J]. Blood, 2015, 126(1): 76-79.
[48]	Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, et al. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction[J]. JAMA Ophthalmol, 2018, 136(10): 1098-1104.
[49]	Yonese I, Takase H, Yoshimori M, et al. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential[J]. Eur J Haematol, 2019, 102(2): 191-196.
[50]	Carbonell D, Mahajan S, Chee SP, et al. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma[J]. Ocul Immunol Inflamm, 2021, 29(3): 507-520.
[51]	Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid[J]. Jpn J Ophthalmol, 2009, 53(3): 209-214.
[52]	Tanaka R, Kaburaki T, Taoka K, et al. More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: a prospective observational study[J]. Ocul Immunol Inflamm, 2021: 1873394.

Please choose a citation manager

Content to export